Mutant OPAA enzyme with increased catalytic efficiency on GP

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10363289
SERIAL NO

15840412

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention is directed toward mutant, non-wild-type organophosphorus acid anhydrolase enzymes having three site mutations, methods of production, and methods of use to effectively degrade toxic organophosphorus compounds, most preferably GP (2, 2′-dimethylcyclopentyl methylphosphonofluoridate).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMYWASHINGTON DC

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Guelta, Mark A White Marsh, US 22 83
Harvey, Steven P Lutherville, US 17 49
McMahon, Leslie R Aberdeen, US 3 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 30, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 30, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00